論治療性克隆技術(shù)的可專利性.pdf

1、 2行論證分析，得出治療性克隆技術(shù)可專利性的倫理障礙是不足以阻礙其獲得《專利法》保護(hù)的。 第四部分對(duì)治療性克隆技術(shù)可專利性的法律障礙： 消極條件和積極條件， 即 《利法》保護(hù)的客體范圍與“三性”要求等方面分析論證后，得出治療性克隆技術(shù)是滿足專利權(quán)保護(hù)的實(shí)質(zhì)條件的。 第五部分對(duì)治療性克隆研究規(guī)范管理以及社會(huì)利益等方面的問(wèn)題談了下自己的想法。最后得出治療性克隆技術(shù)是可以得到專利權(quán)保護(hù)的結(jié)論。 關(guān)鍵詞：治療性克隆技術(shù)；人類胚胎；倫理；可專利性

2、 Abstract Therapeutic cloning technology, means that putting a somatic cell nucleus transferred to a go nuclear egg by the nuclear transfer technology, and through discharge activation cloned human embryos, and then in

3、a laboratory setting produced embryonic stem cells, and induced its differentiation developed into different tissues and organs for transplantation in the treatment of nuclei providers a clone technology. Such technology

4、 method, because with their own cells for nuclear donor, cloned cells, tissues and organs will have the same genetic characteristics as patients, such transplanted into the patients' bodies will not cause immune reje

5、ction. And embryonic stem cells can be infinitely, on the amount is completely can ensure treatment needs. Therefore, once the technology development mature and applied to clinical, can completely solve the allogeneic or

6、gan transplantation worrying immune rejection and the problem of shortage of donors source about organization ,so to broad plagued by sickness, suffering like diabetes, Parkinson's disease, liver cirrhosis, kidney fa

7、ilure and so on, therapeutic cloning technology is undoubtedly disruptive technologies. Faced with such a huge medical value and new biological technology, whether should give therapeutic cloning technology patent protec

8、tion in order to promote its rapid development? At present, the international on this has wide divergence, domestic and international related research also has not been formed general conclusion. Investigate its reason,